Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2019 4
2020 7
2021 8
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Iranian Society of Cardiac Surgeons COVID-19 task force version II, restarting elective surgeries.
Alizadeh Ghavidel A, Mirzaaghayan M, Yousefnia MA, Asdaghpour E, Baghaei Tehrani R, Jalilifar N, Radmehr H, Shirzad M, Austine N, Ahmadi H, Ahmadi ZH, Afrasiabi Rad A, Amirghofran A, Amin A, Ansari Aval Z, Babazadeh K, Bakhshandeh A, Baharestani B, Parvizi R, Jadbabaei A, Jahangirifard A, Hoseini S, Hekmat M, Heidari A, Shabani M, Sadeghipour P, Salehi M, Ziabakhsh Tabari S, Abbasi M, Gholampour Dahaki M, Firouzi A, Laali M, Mandegar MH, Mirmohammadsadeghi M, Navvabi Shirazi M, Nikpajooh A. Alizadeh Ghavidel A, et al. Among authors: shabani m. J Cardiovasc Thorac Res. 2020;12(3):158-164. doi: 10.34172/jcvtr.2020.28. Epub 2020 Jul 22. J Cardiovasc Thorac Res. 2020. PMID: 33123320 Free PMC article. Review.
Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial.
Alavi Darazam I, Shokouhi S, Mardani M, Pourhoseingholi MA, Rabiei MM, Hatami F, Shabani M, Moradi O, Gharehbagh FJ, Irvani SSN, Amirdosara M, Hajiesmaeili M, Rezaei O, Khoshkar A, Lotfollahi L, Gachkar L, Dehbsneh HS, Khalili N, Soleymaninia A, Kusha AH, Shoushtari MT, Torabinavid P. Alavi Darazam I, et al. Among authors: shabani m. Int Immunopharmacol. 2021 Oct;99:107969. doi: 10.1016/j.intimp.2021.107969. Epub 2021 Jul 10. Int Immunopharmacol. 2021. PMID: 34273635 Free PMC article. Review.
Efficacy of Hemoperfusion in Severe and Critical Cases of COVID-19.
Alavi Darazam I, Kazempour M, Pourhoseingholi MA, Hatami F, Rabiei MM, Javandoust Gharehbagh F, Amirdosara M, Hajiesmaeili M, Shabani M, Shokouhi S, Lotfollahi L, Mardani M, Haghighi-Morad M, Nassiri AA, Rangraz D, Falahaty H, Syami H, Irannejad Y, Fallah M, Zangi M, Shafigh N. Alavi Darazam I, et al. Among authors: shabani m. Blood Purif. 2023;52(1):8-16. doi: 10.1159/000524606. Epub 2022 May 17. Blood Purif. 2023. PMID: 35580567 Free PMC article.
Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER).
Mobarak S, Salasi M, Hormati A, Khodadadi J, Ziaee M, Abedi F, Ebrahimzadeh A, Azarkar Z, Mansour-Ghanaei F, Joukar F, Yeganeh S, Yaghubi Kalurazi T, Naghipour M, Mehrabi Z, Bahadori AR, Yaghoubi S, Moslemi R, Abbaspour Kasgari H, Fakheri H, Moghimi M, Shabani AM, Nekoukar Z, Babamahmoodi F, Davoudi Badabi AR, Davoodi L, Hassaniazad M, Barahimi E, Tousi A, Sadeghi A, Hosamirudsari H, Ali Asgari A, Abdollahi M, Anushiravani A, Shabani M, Shokouhi S, Khajavirad N, Salehi M, Dehghan Manshadi SA, Mousavi H, Zolfaghari F, Azimi E, Zeinali A, Akbarpour E, Merat D, Eslami G, Mousaviasl S, Sayar S, Radmanesh E, Ebrahimzadeh M, Arizavi Z, Jelvay S, Salmanzadeh S, Esmaeilian H, Mobarak M, Karimi J, Poormontaseri Z, Hasooni Bahrini N, Bonyadi A, Dehghani F, Mirzaei H, Noori Jangi M, Pourmasoomi H, Rezaie Keikhaie L, Afshari M, Nateghi Baygi A, Nateghi Baygi H, Levi J, McCann K, Wentzel H, Simmons B, Hill A, Merat S. Mobarak S, et al. Among authors: shabani m. J Antimicrob Chemother. 2022 Feb 23;77(3):758-766. doi: 10.1093/jac/dkab433. J Antimicrob Chemother. 2022. PMID: 34849957 Free PMC article. Clinical Trial.
Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial.
Alavi Darazam I, Shokouhi S, Pourhoseingholi MA, Naghibi Irvani SS, Mokhtari M, Shabani M, Amirdosara M, Torabinavid P, Golmohammadi M, Hashemi S, Azimi A, Jafarazadeh Maivan MH, Rezaei O, Zali A, Hajiesmaeili M, Shabanpour Dehbsneh H, Hoseyni Kusha A, Taleb Shoushtari M, Khalili N, Soleymaninia A, Gachkar L, Khoshkar A. Alavi Darazam I, et al. Among authors: shabani m. Sci Rep. 2021 Apr 13;11(1):8059. doi: 10.1038/s41598-021-86859-y. Sci Rep. 2021. PMID: 33850184 Free PMC article. Clinical Trial.
20 results